期刊文献+

人锌转运体8强免疫原性片段的预测及原核表达鉴定

Prediction of highly immunogenic fragment of human zinc transporter 8 and identification of its expression in prokaryotic system
下载PDF
导出
摘要 目的筛选人锌转运体8(Zinc transporter8,ZnT8)中强免疫原性片段,并对其进行克隆表达及鉴定。方法采用生物信息学软件预测ZnT8结构特征,筛选出具有强免疫原性的N末端片段ZnT8(N),经PCR(Polymerase Chain Reaction)技术扩增,构建表达质粒pET32a-ZnT8(N),转化入E.coliBL21(DE3)中,异丙基-β-D-硫代半乳糖苷(IPTG)诱导目的蛋白的表达,并对表达产物进行SDS-PAGE分析及Westernblot鉴定。结果从ZnT8分子中筛选出具有140个氨基酸的肽段ZnT8(N),重组质粒pET32a-ZnT8(N)经酶切和测序鉴定证实构建成功。转入大肠杆菌进行表达,表达产物相对分子质量(Mr)约32000,与预期值相符,并经免疫印迹检测鉴定为阳性,融合蛋白的表达量约占菌体蛋白总量45%。结论筛选获得了人胰岛细胞来源的ZnT8强免疫原性片段,并在原核系统中成功表达。 Objective To screen highly immunogenic fragment of human zinc transporter 8 ( ZnT8) and to identify its expression in prokaryotic system. Methods Characteristics of ZnT8 structure were detected using bioinformatics software. A highly immunogenic fragment of ZnT8 was screened at the N-terminal and amplified by polymerase chain reaction ( PCR). Expression plasmid pET32a-ZnT8 ( N) was constructed and transformed to E. coli BL21( DE3). Expression of target protein was induced by isopropyl β-D-1-Thiogalactopy-ranoside( IPTG). Expressed products were analyzed using SDS-PAGE and identified by Western blotting. Results The screened ZnT8 ( N) fragment had 140 amino acids. Recombinant pET32a-ZnT8 ( N) was successfully constructed,which was confirmed by restriction analysis. The relative molecular weight of expressed products was about 32 × 103 after transformed into E. coli,which was consistent with the expected value. Western blot analysis showed that the positively expressed products contained over 45% of the total fused protein. Conclusion A highly immunogenic fragment of ZnT8 can be screened from human islet cells,which is expressed in the prokaryotic system.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2010年第11期1162-1164,共3页 Journal of Third Military Medical University
基金 第三军医大学临床科研基金(2008XG20)~~
关键词 ZnT8 原核表达 免疫原性 ZnT8 prokaryote expression immunogenicity
  • 相关文献

参考文献10

  • 1Wenzlau J M, Moua O, Sarkar, - S - A, et al. SIC30A8 is a major target of humoral autoimmunity in type 1 diabetes and a predictive marker in prediabetes[J]. Ann NY Acad Sci, 2008, 1150:256-259.
  • 2张丽,程慧玲,索翠萍.糖尿病相关抗原及其抗体的研究进展和临床应用[J].医学检验与临床,2006,18(6):72-73. 被引量:1
  • 3Chimienti F, Devergnas S, Pattou F, et al. In vivo expression and functional characterization of the zinc transporter ZnT8 in glucose-induced insulin secretion [ J ]. J Cell Sci, 2006, 119 ( Pt 20 ) : 4199 - 4206.
  • 4Wenzlau J M, Juhl K, Yu L, et al. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes[J].Proc Natl Acad Sci U S A, 2007, 104(43) : 17040- 17045.
  • 5Beyersmann D, Haase H. Functions of zinc in signaling, proliferation and differentiation of mammalian cells[J]. Biometals, 2001, 14(3/4) : 331 - 341.
  • 6Aydemir T B, Blanehard R K, Cousins R J. Zinc supplementation of young men alters metallothionein, zinc transporter, and cytokine gone expression in leukocyte populations[ J ]. Proc Natl Acad Sci U S A, 2006, 103(6): 1699-1704.
  • 7Chimienti F, Favier A, Sere M. ZnT-8, a pancreatic beta-cell-specific zinc transporter[J]. Biometals, 2005, 18(4) : 313 -317.
  • 8Achenbach P, l,ampasona V, Landherr U, et al. Autoantibodies to zinc transporter 8 and SLC30A8 genotype stratify type 1 diabetes risk [J]. Diabetologia, 2009, 52(9) : 1881 - 1888.
  • 9Wenzlau J M, Frisch L M, Gardner T J, et al. Novel antigens in type 1 diabetes: the importance ofZnT8[J]. Curt Diab Rep, 2009, 9(2) : 105 - 112.
  • 10Chimienti F, Devergnas S, Favier A, et al. Identification and cloning of a beta-cell-specific zinc transporter, ZnT-8, localized into insulin secretory granules[ J ]. Diabetes, 2004,53 (9) : 2330 - 2337.

二级参考文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部